Founder of BIOptima Advisors LLC, Elizabeth Adkins Czerepak presently is Chief Financial Officer & Executive Vice President of Sorrento Therapeutics, Inc. and Chief Financial Officer of BeyondSpring, Inc.
She is also on the board of Delcath Systems, Inc. and Member of Licensing Executives Society.
In the past she was CFO, Secretary & EVP-Corporate Development at Altimmune, Inc. and Chief Financial Officer at Altimmune, Inc. (a subsidiary of Altimmune, Inc.), Chief Financial & Business Officer at Isarna Therapeutics, Inc., Managing Director at JPMorgan Chase & Co. Managing Director at Bear, Stearns & Co., Inc. and Managing Partner at Bear Stearns Health Innoventures Management LLC (both are subsidiaries of JPMorgan Chase & Co.), CFO, Secretary & Principal Accounting Officer at Cancer Genetics, Inc., Chief Financial & Business Officer at Genevant Sciences Corp., Principal at Hoffmann-La Roche, Inc., Director & Vice President-Business Development at BASF Pharma Ltd. and Director & Vice President-Business Development at Knoll Pharmaceutical Co.
She received an MBA from Rutgers State University of New Jersey and an undergraduate degree from Marshall University.